Breathe Well Live Well
|
U of L physicians first in Kentucky to offer new asthma treatment
Louisville Business First Physicians with the pulmonary, critical care and sleep disorders medicine practice of University Medical Associates, with University of Louisville Hospital , are the first in Kentucky to offer a new asthma treatment. The Alair Bronchial Thermoplasty … |
View full post on asthma – Google News
|
Asthma drug omalizumab cuts treatment needs
Nursing Times Severe persistent allergic asthma sufferers treated with omalizumab have been shown to use far fewer NHS resources than those treated with other drugs. The drug, marketed as Xolair, has also been shown to significantly improve users' health-related … Novartis study shows cost-effectiveness benefits of Xolair |
View full post on asthma – Google News
 Zee News |
Treatment of asthma and allergies identified
Zee News Washington: Scientists have identified the histamine releasing factor (HRF) molecule as a promising target for developing new treatments for a number of allergic reactions including asthma. In the new study, Toshiaki Kawakami and his team of … Asthma And Allergies – HRF Molecule Is A Promising Target For Treatment |
View full post on asthma – Google News
|
Researchers Find New Molecular Candidates For Treatment of Asthma and Allergies
Newswise (press release) The research team, led by Toshiaki Kawakami, MD, Ph.D., is also the first to clarify the role of the HRF molecule in promoting asthma and some allergies, including identifying its receptor – a major finding that answers a long-held and important … |
View full post on asthma – Google News
|
Asthma And Allergies – HRF Molecule Is A Promising Target For Treatment
Medical News Today The histamine releasing factor (HRF) molecule has been identified by researchers at La Jolla Institute for Allergy & Immunology, as a potential target for developing novel therapies for numerous allergic reactions, including asthma. … |
View full post on asthma – Google News
|
La Jolla Institute finds new molecular candidates for treatment of asthma and …
EurekAlert (press release) SAN DIEGO – (December 1, 2011) La Jolla Institute for Allergy & Immunology scientists have identified the histamine releasing factor (HRF) molecule as a promising target for developing new treatments for a number of allergic reactions including asthma. … |
View full post on asthma – Google News
|
Washington U. study examines asthma treatment
STLtoday.com For many asthma sufferers, medications don't work well in controlling their symptoms. Washington University School of Medicine researchers want to see if vitamin D supplements can help. Several studies have linked low vitamin D levels in asthma … |
View full post on asthma – Google News
|
University Hospital First in Southeast to Offer New Treatment for Severe Asthma
The Emory Wheel Emory University Hospital has become the first hospital in the Southeast region to offer bronchial thermoplasty, a new treatment for people with severe asthma that permanently reduces the number and severity of … |
View full post on asthma – Google News
 Rutland and Stamford Mercury |
More than half asthma sufferers have no access to life-changing treatment
Irish Independent MORE than half of Ireland's severe asthma sufferers have no access to potentially life-changing treatment which is available to others, campaigners have warned. The Asthma Society of Ireland (ASI) said if medication only available in … Many missing out on vital asthma drug |
View full post on asthma – Google News
|
In the Treatment of Asthma, Merck's Singulair Accounts for More Than a Quarter …
MarketWatch (press release) Analysis of US patient-level claims data from Treatment Algorithms in Asthma also finds that more than half of newly diagnosed asthma patients that move to the second line of therapy within a year of diagnosis are treated with Singulair. … |
View full post on asthma – Google News